Interaction of endothelin-1 and nitric oxide pathways in human tubular epithelial cells under the influence of cyclosporine-A

Renal Failure

Volumn 32, Issue 6, 2010, Pages 727-732

  Papachristou, Evangelos ^a   Papadimitropoulos, Athanasios ^b   Kotsantis, Panagiotis ^b   Goumenos, Dimitrios S ^a   Katsoris, Panagiotis G ^b   Vlachojannis, John G ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

Author keywords

Cyclosporine; Endothelin; Nephrotoxicity; Nitric oxide

Indexed keywords

CYCLOSPORIN A; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; NITRIC OXIDE;

ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; ENZYME INDUCTION; ENZYME SYNTHESIS; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; KIDNEY TUBULE CELL; MOLECULAR INTERACTION; NEPHROTOXICITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SYNTHESIS; UPREGULATION; WESTERN BLOTTING;

BIOSYNTHETIC PATHWAYS; CELLS, CULTURED; CYCLOSPORINE; ENDOTHELIN-1; EPITHELIAL CELLS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; KIDNEY TUBULES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

EID: 77953562677     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2010.486487     Document Type: Article

References (24)

1. Cohen DJ, Loertscher R, Rubin MF, Tilney NL, Carpenter CB, Strom TB. Cyclosporine: A new immunosuppressive agent for organ transplantation. Ann Intern Med. 1984;101: 667-682.
2. McMorrow T, Gaffney MM, Slattery C, Campbell E, Ryan MP. Cyclosporine A induced epithelial-mesenchymal transition in human renal proximal tubular epithelial cells. Nephrol Dial Transplant. 2005;20:2215-2225.
3. Bennett WM, DeMattos A, Meyer MM, Andoh T, Barry JM. Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy. Kidney Int. 1996;50:1089-1100.
4. McNally PG, Feehally J. Pathophysiology of cyclosporin A nephrotoxicity: Experimental and clinical observations. Nephrol Dial Transplant. 1992;7:791-804.
5. Dhaun N, Goddard J, Webb DJ. The endothelin system and its antagonism in chronic kidney disease. J Am Soc Nephrol. 2006;17:943-955.
6. Kohan DE. Endothelins in the normal and diseased kidney. Am J Kidney Dis. 1997;29:2-26.
7. Drakopoulos A, Goumenos DS, Vlachojannis JG, Tsakas S. Endothelin receptors in the kidney of patients with proteinuric and non-proteinuric nephropathies. Ren Fail. 2006;28: 461-467.
8. Goligorsky MS, Brodsky SV, Noiri E. Nitric oxide in acute renal failure: NOS versus NOS. Kidney Int. 2002;61:855-861.
9. Gabbai FB, Blantz RC. Role of nitric oxide in renal hemodynamics. Semin Nephrol. 1999;19:242-250.
10. Amore A, Emancipator S, Cirina P, et al. Nitric oxide mediates cyclosporine-induced apoptosis in cultured renal cells. Kidney Int. 2000;57:1549-1559.
11. Prabhakar SS. Regulatory and functional interaction of vasoactive factors in the kidney and extracellular pH. Kidney Int. 2004;66:1742-1754.
12. Papachristou E, Papadimitropoulos A, Kotsantis P, Goumenos DS, Katsoris PG, Vlachojannis JG. Cyclosporine induces endothelin-1 mRNA synthesis and nitric oxide production in human proximal tubular epithelial cell cultures. Ren Fail. 2009;31(5):372-376.
13. Bunchman TE, Brookshire CA. Cyclosporine-induced synthesis of endothelin by cultured human endothelial cells. J Clin Invest. 1991;88:310.
14. Perico N, Dadan J, Remuzzi G. Endothelin mediates the renal vasoconstriction induced by cyclosporine in the rat. J Am Soc Nephrol. 1990;1:76.
15. Bartholomeusz B, Hardy KJ, Nelson AS, Phillips PA. Bosentan ameliorates cyclosporin A-induced hypertension in rats and primates. Hypertension. 1996;27:1341-1345.
16. Fogo A, Hellings SE, Inagami T, Kon V. Endothelin receptor antagonism is protective in in vivo acute cyclosporin toxicity. Kidney Int. 1992;42:770-774.
17. Slowinski T, Subkowski T, Diehr P, et al. Interaction of the endothelin system and calcineurin inhibitors after kidney transplantation. Clin Sci (Lond). 2002;103:396S.
18. Bobadilla NA, Gamba G, Tapia E, et al. Role of NO in cyclosporin nephrotoxicity: Effects of chronic NO inhibition and NO synthases gene expression. Am J Physiol. 1998;274: F791-798.
19. Kurus M, Esrefoglu M, Bay A, Oztürk F. Protective effect of oral L-arginine supplementation on cyclosporine induced nephropathy in rats. Int Urol Nephrol. 2005;37:587-594.
20. Boulanger C, Luscher TF. Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest. 1990;85:587-590.
21. Luscher TF, Yang Z, Tschudi M, et al. Interaction between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins. Circ Res. 1990;66:1088-1094.
22. Mitsutomi N, Akashi C, Odagiri J, Matsumura Y. Effects of endogenous and exogenous nitric oxide on endothelin-1 production in cultured vascular endothelial cells. Eur J Pharmacol. 1999;364:65-73.
23. De Nucci G, Thomas R, D'Orleans-Juste P, et al. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci U S A. 1988;85:9797-9800.
24. Tack I, Marin-Castano E, Bascands JL, Pecher C, Ader JL, Girolami J-P. Cyclosporine A-induced increase in glomerular cyclic GMP in rats and the involvement of the endothelin B receptor. Br J Pharmacol. 1997;121:433-440.